3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
2
Thoracic
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Breast Neoplasms
11
Triple Negative Breast Neoplasms
10
Prostatic Neoplasms
4
Pancreatic Neoplasms
4
Neoplasm Metastasis
4
Ovarian Neoplasms
3
Uterine Neoplasms
2
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Multiple Myeloma
2
Melanoma
2
Lung Neoplasms
2
Hematologic Neoplasms
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Transitional Cell
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Anatomic Stage II Breast Cancer AJCC v8
2
Urologic Neoplasms
1
Thrombocytosis
1
Stomach Neoplasms
1
Soft Tissue Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Primary Myelofibrosis
1
Interventions
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Biopsy
2
trastuzumab deruxtecan
1
sargramostim
1
rucaparib
1
rebastinib
1
pembrolizumab
1
ceralasertib
1
belinostat
1
X-Rays
1
Paclitaxel
1
Nivolumab
1
Immunoglobulin G
1
Fluorouracil
1
DCC-2036
1
Cyclophosphamide
1
Colony-Stimulating Factors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinosarcoma
×
Immunoglobulin G
×
Breast
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled